Hoffmann-Vold AM, Petelytska L, Fretheim H, Aaløkken TM, Becker MO, Jenssen Bjørkekjær H, Brunborg C, Bruni C, Clarenbach C, Diep PP, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Huang S, Jordan S, Langballe E, Midtvedt Ø, Mihai C, Mulcaire-Jones E, Pugashetti JV, Sprecher M, Oldham J, Molberg Ø, Khanna D et al. (2025)
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study
Lancet Rheumatol (in press)
DOI 10.1016/S2665-9913(25)00026-8, PubMed 40381640

Kvitting JP, Ravnestad H, Andersen R, Gjønnæss E, Moe N, Birkeland S, Svalebjørg M, Lingaas PS, Gude E, Gullestad L, Broch K, Andreassen AK (2025)
Chronic thromboembolic pulmonary hypertension
Tidsskr Nor Laegeforen, 145 (4)
DOI 10.4045/tidsskr.24.0508, PubMed 40145212

Kvitting JP, Ravnestad H, Andersen R, Gjønnæss E, Moe N, Birkeland S, Svalebjørg M, Lingaas PS, Gude E, Gullestad L, Broch K, Andreassen AK (2025)
[Correction: Chronic thromboembolic pulmonary hypertension]
Tidsskr Nor Laegeforen, 145
DOI 10.4045/tidsskr.25.0191, PubMed 40145849